These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18506103)

  • 1. MeCP2 knockdown reveals DNA methylation-independent gene repression of target genes in living cells and a bias in the cellular location of target gene products.
    Yakabe S; Soejima H; Yatsuki H; Tominaga H; Zhao W; Higashimoto K; Joh K; Kudo S; Miyazaki K; Mukai T
    Genes Genet Syst; 2008 Apr; 83(2):199-208. PubMed ID: 18506103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated.
    Kudo S
    Mol Cell Biol; 1998 Sep; 18(9):5492-9. PubMed ID: 9710633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A/T Run Geometry of B-form DNA Is Independent of Bound Methyl-CpG Binding Domain, Cytosine Methylation and Flanking Sequence.
    Chia JY; Tan WS; Ng CL; Hu NJ; Foo HL; Ho KL
    Sci Rep; 2016 Aug; 6():31210. PubMed ID: 27502833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical analysis of histone deacetylase-independent transcriptional repression by MeCP2.
    Theisen JW; Gucwa JS; Yusufzai T; Khuong MT; Kadonaga JT
    J Biol Chem; 2013 Mar; 288(10):7096-104. PubMed ID: 23349465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain.
    Lei M; Tempel W; Chen S; Liu K; Min J
    Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194409. PubMed ID: 31356990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.
    Yasui DH; Peddada S; Bieda MC; Vallero RO; Hogart A; Nagarajan RP; Thatcher KN; Farnham PJ; Lasalle JM
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19416-21. PubMed ID: 18042715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methyl-CpG-binding protein MeCP2 and neurological disease.
    Bird A
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):575-83. PubMed ID: 18631120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.
    Fujita N; Shimotake N; Ohki I; Chiba T; Saya H; Shirakawa M; Nakao M
    Mol Cell Biol; 2000 Jul; 20(14):5107-18. PubMed ID: 10866667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
    Klose RJ; Sarraf SA; Schmiedeberg L; McDermott SM; Stancheva I; Bird AP
    Mol Cell; 2005 Sep; 19(5):667-78. PubMed ID: 16137622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells.
    Xu M; Bian S; Li J; He J; Chen H; Ge L; Jiao Z; Zhang Y; Peng W; Du F; Mo Y; Gong A
    Oncotarget; 2016 Mar; 7(12):14476-85. PubMed ID: 26910839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
    Yu F; Zingler N; Schumann G; Strätling WH
    Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian methyl-binding proteins: what might they do?
    Joulie M; Miotto B; Defossez PA
    Bioessays; 2010 Dec; 32(12):1025-32. PubMed ID: 20886526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC; Schübeler D; Groudine M
    Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
    Drewell RA; Goddard CJ; Thomas JO; Surani MA
    Nucleic Acids Res; 2002 Mar; 30(5):1139-44. PubMed ID: 11861904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of DNA methylation as a facilitator of target search processes for transcription factors through interplay with methyl-CpG-binding proteins.
    Kemme CA; Marquez R; Luu RH; Iwahara J
    Nucleic Acids Res; 2017 Jul; 45(13):7751-7759. PubMed ID: 28486614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.